Can Pharmakogenetik Medicheck help with Langlebigkeit?

Pharmacogenetics (PGx) examines how genetic variants affect drug metabolism and response. A PGx test like 'Medicheck' can help personalize medication – for example, with statins, beta-blockers, or antidepressants. This may reduce adverse effects and improve adherence, indirectly supporting health in older age. However, there is no direct, high-quality evidence that PGx tests extend lifespan (longevity). Longevity is determined by many factors: genetics, lifestyle, environment, and chance. PGx addresses only a small piece – drug tolerability. Most PGx markers (e.g., CYP2C19, CYP2D6) are validated for drug metabolism, not for longevity. Consumer tests often oversimplify and exaggerate clinical relevance. A PGx test can be useful if you take regular medications, but it does not replace medical advice. For 'longevity' in the sense of healthy aging, blood biomarkers, exercise, nutrition, and sleep are more important. Evidence: strong for drug response, but weak for direct longevity. Sources: CPIC guidelines, PMIDs for CYP2C19/statins.